Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

MEA115588 A randomised, double-blind, double-dummy, placebo-controlled, parallel-group, multi-centre study of the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe uncontrolled refractory asthma
mepolizumab
MEA115588
NCT01691521
Asthma
Phase 3
 
A follow-on study MEA115661 was conducted. This study is available in CDISC format
November 2015

Powered by ideaPoint, Inc.